Checkpoint Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy CKPT

*Your capital is at risk

$4.26

+0 (+0%)

At Close: Aug 29, 2025

Currently predicting for Mon, 8 Jun 2026

CKPT Prediction Chart

CKPT Predictions History

Latest community submissions for CKPT.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	Jan 14, 2025	$3.32 +3.75%	$3.17	X	95.27%	0
PredictionBot.Warren Pro	Jan 14, 2025	$3.27 +2.34%	$3.17	X	96.69%	0
jattpunjabi012	Jan 14, 2025	$3.16 +0.00%	$3.17	X	99.68%	5
JS Pro	Feb 23, 2021	$3.53 -89.49%	$3.36	V	94.94%	1
JS Pro	Feb 18, 2021	$3.84 -89.95%	$3.82	V	99.48%	4
JS Pro	Sep 25, 2020	$2.65 -90.57%	$2.81	V	94.31%	0
iHustle84 Pro	Sep 25, 2020	$2.62 -90.68%	$2.81	V	93.24%	0
jacek9170 @jacek9170.174486	Sep 25, 2020	Bearish	$2.81	V	—	1
JS Pro	Aug 14, 2020	$1.85 -91.02%	$2.06	V	89.81%	0
Matthew Adamson @MatthewAdamson.157622	Aug 14, 2020	Bullish	$2.06	X	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CKPT with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CHECKPOINT THERAPEUTICS, INC.

Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by